Clinical trial of bromhexine in severe chronic bronchitics during winter
In a double-blind, controlled cross-over trial, the effect of the mucolytic drug bromhexine (24 mg or 48 mg daily) was compared with a placebo over a period of 14 weeks in 21 severe chronic bronchitics (mean FEV(1·0) 0·8 1.). Each of the three treatment regimes was continued for four weeks with inte...
Furkejuvvon:
| Publikašuvnnas: | Thorax |
|---|---|
| Váldodahkkit: | , , |
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMJ Publishing Group
1972
|
| Fáttát: | |
| Liŋkkat: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC469946/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4561679/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.27.4.429 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|